Intuitive Surgical Inc. (ISRG) delivered a solid fourth quarter Thursday, posting results that handily exceeded Wall Street's expectations as demand for robotic-assisted surgery continues to expand.

The Numbers Tell a Strong Story

The medical robotics company reported revenue of $2.87 billion for the fourth quarter, surpassing analyst estimates of $2.75 billion, according to market data. Adjusted earnings came in at $2.53 per share, well ahead of the $2.26 consensus estimate.

Total revenue climbed 19% year-over-year, powered by increasing procedure volumes, higher da Vinci system placements, and a growing installed base. Worldwide da Vinci procedures grew approximately 18% compared to the prior year's quarter, reflecting steady adoption across the healthcare landscape.

Intuitive Surgical placed 532 da Vinci surgical systems during the quarter, compared to 493 in the same period last year. By the end of December 2025, the company's installed base had reached 11,106 systems, marking a 12% year-over-year increase.

The company's balance sheet remains robust, with $9.03 billion in cash, cash equivalents and investments—up $600 million during the quarter.

Tempering Growth Expectations for 2026

Looking ahead, Intuitive expects full-year 2026 worldwide da Vinci procedures to grow approximately 13% to 15%, a moderation from the 18% growth seen in 2025. The company projects gross profit margin to land between 67% and 68% of revenue in 2026, compared to 67.6% in 2025.

Management planned to discuss the results in greater detail during an earnings call scheduled for 4:30 p.m. ET Thursday.

Market Reaction

ISRG Price Action: Intuitive Surgical shares were up 3.04% in after-hours trading, changing hands at $541.78 at the time of publication Thursday.